Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.73%
#2 Biconomy Biconomy +21.23%
#3 MiL.k Alliance MiL.k Alliance +19.09%
#4 THORChain THORChain +17.34%
#5 Wrapped STX (Velar) Wrapped STX (Velar) +16.07%
#6 Bless Bless +15.17%
#7 Tutorial Tutorial +14.78%
#8 TENDIES TENDIES +14.50%
#9 Gigachad Gigachad +14.44%
#10 XPIN Network XPIN Network +13.56%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Sam Chun Dang Pharm. Co., Ltd Sam Chun Dang Pharm. Co., Ltd

Sam Chun Dang Pharm. Co., Ltd

000250
Clasificación en acciones #5349
Sam Chun Dang Pharm Co., Ltd. is a pharmaceutical company that develops and... Sam Chun Dang Pharm Co., Ltd. is a pharmaceutical company that develops and produces a wide variety of medications. Its product range features antibiotics, treatments for cardiovascular and respiratory conditions, drugs for the digestive system and ophthalmic use, as well as anti-inflammatory agents. The company was founded on December 29, 1943, and its main operations are based in Hwaseong-si, South Korea.
Precio por acción
$118.66
Capitalización bursátil
$2.78B
Cambio (1 día)
0.29%
Cambio (1 año)
-14.79%
País
KR
Comercio Sam Chun Dang Pharm. Co., Ltd (000250)

Categoría

Healthcare
Ganancias de Sam Chun Dang Pharm. Co., Ltd (000250)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Sam Chun Dang Pharm. Co., Ltd, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Sam Chun Dang Pharm. Co., Ltd desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$992.42M -
HK